Definition of BE (EMA) [Design Issues]

posted by Dr_Dan  – Germany, 2014-08-11 02:10 (4336 d 23:25 ago) – Posting: # 13360
Views: 9,452

Dear BarbaraM
First of all one question: Do you need to dose patients? I guess this is the case, right? Bad luck.... You can not mix two strenghts (500 mg and 1000 mg = two formulations) for the assessment of bioequivalence. I would go for a scientific advice proposing the execution of the study with the lower strength.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
150 visitors (0 registered, 150 guests [including 16 identified bots]).
Forum time: 01:36 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5